OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
He doesn’t sound intimidated, after giving to Trump’s inaugural.
In a long and wistful blog post titled ‘Reflections’ Sam Altman, the mercurial CEO of ChatGPT creators OpenAI, has said that he believes we will achieve AGI (artificial general intelligence ...
says OpenAI CEO Sam Altman. "There will be a kind of ability we still really value, but it will not be raw, intellectual horsepower to the same degree," Altman told Wharton organizational ...